Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
DIALANYL SYRUP 100ML
- Sku : I-001678
Key features
DIALANYL Syrup is a prescription oral syrup containing terbutaline 0.3 mg/ml. It is a selective short-acting beta-2 adrenergic receptor agonist that relaxes bronchial smooth muscle to produce bronchodilation and relieve bronchospasm. It is used for relief and prevention of bronchospasm in reversible obstructive airway diseases such as bronchial asthma and in conditions with bronchospasm including chronic bronchitis and emphysema/COPD. Available as a 100 ml bottle for prescription dispensing.- Brand: DILANYL
- Active Ingredient: TERBUTALINE
- Strength: 0.3mg/ml
- Dosage Form: Syrup
- Pack Size: 100 ml
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Respiratory
- Pharmacological Group: Anti-asthma & COPD
- Drug Class: Selective short-acting beta-2 adrenergic agonist (SABA).
- Manufacturer: KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES
- Country of Origin: Kuwait
- SFDA Registration No.: 1006245401
- Shelf Life: 36 months
- Storage: Store below 30°C , protect from Light
- Symptom Target: Terbutaline is used to prevent bronchospasm and relieve cough, wheezing, shortness of breath, and troubled breathing in asthma, bronchitis, emphysema, and other lung diseases. While cough relief may occur as a secondary effect, the primary indication is bronchospasm prevention and relief, not cough as a standalone symptom.
- Sedating: No
Frequently bought together
Indications
Approved Uses
Relief and prevention of bronchospasm in reversible obstructive airway disease (e.g., bronchial asthma) and other conditions with bronchospasm such as chronic bronchitis and emphysema/COPD.
Off-Label Uses
Tocolysis (delaying preterm labor) is an off-label/region-dependent use, typically with parenteral terbutaline; other proposed uses (e.g., hyperkalemia) are not standard and are not routinely recommended.
Dosage & Administration
Dosing by Condition
Oral terbutaline dosing is individualized by age/weight and local label; typical references use adults 2.5-5 mg orally three times daily (max often 15 mg/day) and pediatrics weight-based dosing (e.g., ~0.075 mg/kg/dose three times daily with per-dose maximums per label).
Initial Dose
Adults: 2.5-5 mg three times daily. Children (12-15 years): 2.5 mg three times daily.
Maintenance Dose
Adults: 2.5-5 mg three times daily; Children: 0.075 mg/kg three times daily
Maximum Dose
Adults: 15 mg per 24 hours. Children (12-15 years): 7.5 mg per 24 hours.
Children's Dosage
Children 2-14 years: 0.075 mg/kg (0.25 ml/kg) three times daily, maximum 2.5 mg (8.3 ml) per dose; Children under 2 years: not recommended
How to Take
Oral use: shake well before each dose; measure with a calibrated oral syringe/medicine spoon (not a household spoon); may be taken with or without food; take exactly as prescribed.
Side Effects
Common Side Effects
Tremor, nervousness, headache, dizziness, drowsiness, palpitations, tachycardia, nausea.
Side Effect Frequency
Very common/common: tremor and nervousness are among the most frequent; common: palpitations/tachycardia and headache; other reported effects include nausea and muscle cramps; serious/uncommon: hypokalemia and arrhythmias (frequency varies by source).
Safety & Warnings
Contraindications
Contraindication: hypersensitivity to terbutaline or other sympathomimetic amines; avoid use for tocolysis (particularly prolonged tocolysis) due to serious risk (treated as a contraindicated use in practice).
Warnings & Precautions
Use caution in cardiovascular disease (arrhythmias, ischemic heart disease, hypertension), hyperthyroidism, diabetes, seizure disorders; monitor/consider potassium (especially with high doses or diuretics/xanthines/steroids); discontinue if paradoxical bronchospasm occurs; frequent need indicates poor control requiring reassessment.
Age Restriction
Use of terbutaline in children younger than 12 years of age is not recommended. No specific lower age limit of 2 years is stated in authoritative sources.
Driving Warning
Use caution; may cause dizziness or shakiness
Drug Interactions
Interaction Severity
MAJOR: non-selective beta-blockers (e.g., propranolol) may antagonize effect and precipitate bronchospasm. MODERATE: MAOIs/TCAs may potentiate cardiovascular effects; diuretics (loop/thiazide) and corticosteroids/xanthines may increase hypokalemia risk; other sympathomimetics increase adrenergic effects. Digoxin: monitor due to hypokalemia-related arrhythmia risk.
Special Populations
Breastfeeding
Caution
Children
Children 2-14 years: 0.075 mg/kg (0.25 ml/kg) three times daily, maximum 2.5 mg (8.3 ml) per dose; Children under 2 years: not recommended
Storage & Patient Advice
Storage Conditions
Store below 30°C; protect from light.
Missed Dose
Take as soon as remembered; skip if it is almost time for the next dose. Do not take two doses at once.
Stopping the Medicine
Do not stop or change frequency if used regularly for symptom control without clinician review; if used PRN, it can be stopped when not needed but worsening symptoms require reassessment.
Overdose
Symptoms: tremor, agitation, tachycardia/palpitations, hypertension or hypotension, arrhythmias, hypokalemia, hyperglycemia, possible seizures; management: stop drug, urgent medical care, supportive/monitoring (ECG, potassium/glucose), correct electrolytes, consider a cardioselective beta-blocker with extreme caution (bronchospasm risk).
Patient Counseling
Shake well; measure doses with a calibrated device; do not exceed prescribed frequency/dose; common effects include tremor, nervousness, headache, palpitations-seek care for chest pain, severe palpitations, fainting, or worsening breathing/poor response; keep tightly closed and store below 30°C protected from light (SFDA).
Monitoring Requirements
Monitor clinical response (wheeze/PEF), heart rate and blood pressure; consider serum potassium with high doses or with diuretics/corticosteroids/xanthines; consider blood glucose in diabetics or high-dose therapy.
Pharmacology
Mechanism of Action
Selective beta-2 adrenergic receptor agonist that relaxes bronchial smooth muscle by stimulating beta-2 receptors, leading to bronchodilation and relief of bronchospasm
Product Information
Available Dosage Forms
Oral syrup/solution, tablets, and solution for injection
Composition per Dose
Each 5 ml: 1.5 mg terbutaline sulfate (equivalent to 0.3 mg/ml)
OTC Alternatives
No OTC alternative
Symptom Target
Terbutaline is used to prevent bronchospasm and relieve cough, wheezing, shortness of breath, and troubled breathing in asthma, bronchitis, emphysema, and other lung diseases. While cough relief may occur as a secondary effect, the primary indication is bronchospasm prevention and relief, not cough as a standalone symptom.
Sedating
No
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)



